Bonnie Chapman — the 25-year-old daughter of Duane "Dog the Bounty Hunter" Chapman — revealed she's taking tirzepatide for ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical ...

In the first head-to-head test, people using Eli Lilly’s Zepbound lost just over 50 pounds while those using competitor Novo ...

The state pharmacy board placed two Nevada pharmacists on probation after they dispensed faulty weight loss drugs to local ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...

Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...

which supported the FDA approval of the injectable drug for diabetes, and later, obesity. The new results show that after 176 weeks of treatment, only 1.3% of patients who were both obese and ...

Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss study, boosting market-share gains and stock prices.

Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...